Project Grant R01AG094056
- Federal Grant Award Summary The University of Texas Health Science Center at Houston received a $654,110 Project Grant award from the National Institute on Aging (NIA) under the Aging Research program (CFDA 93.866), effective February 1, 2026, through December 31, 2030. The award supports biomedical research investigating the role of Enhancer of Zeste Homolog 2 (EZH2), an epigenetic modifier, in cerebral amyloid angiopathy (CAA) and Alzheimer's disease (AD) pathology. The research focuses on how...
- Federal Project Grant Award Summary The University of Texas Health Science Center at Houston received a $417,800 Project Grant award from the National Institute on Aging (NIA) under the Aging Research program (CFDA 93.866), effective September 15, 2025, with completion targeted for August 31, 2027. This research initiative focuses on investigating senescence induced by iron overload in the brain vasculature and its role in age-related cognitive dysfunction and dementia pathologies including...
- Federal Project Grant Award Summary The University of Texas Health Science Center at Houston received a $429,000 Project Grant award from the National Institute on Aging (NIA) under the Aging Research program (CFDA 93.866) effective June 1, 2025, through May 31, 2026. This award supports a 12-month research project investigating the role of metal-responsive transcription factors in neurodegenerative diseases, with a focus on understanding how the protein Metal Regulatory Transcription Factor-1...
- Federal Project Grant Award Summary The University of Texas Southwestern Medical Center received a $456,500 Project Grant from the National Institute on Aging under the Aging Research program (CFDA 93.866) effective February 1, 2026, through January 31, 2028. The award supports research investigating the role of heparan sulfate proteoglycans (HSPGs) in tau protein uptake within cell and mouse models relevant to Alzheimer's disease. The project aims to identify the specific heparan sulfate size...
- Federal Project Grant Award Summary Vanderbilt University Medical Center received $1,469,914 in project grant funding from the National Institute on Aging under the Aging Research program (CFDA 93.866) for the period January 1, 2026 through December 31, 2030. The award supports research titled "Probing Mechanistic Links Between Endothelial Aging and Dementia," which develops and applies a novel human induced pluripotent stem cell-endothelial cell (hiPSC-EC) model to investigate the...
- Federal Project Grant Award Summary The University of Texas at Austin received a $438,625 Project Grant from the National Institute on Aging (NIA) under the Aging Research program (CFDA 93.866), awarded September 1, 2025, with completion targeted for August 31, 2027. The research initiative, titled "Decoding the Heterogeneity of Interneuron Vulnerability in Aging and Alzheimer's Disease: An Ultraplex CLEM Approach," will deliver comprehensive scientific investigation into age-related...
- Federal Project Grant Award Summary The University of Texas Health Science Center at San Antonio received a $126,597 Project Grant from the National Institute on Aging (NIA) under the Aging Research program (CFDA 93.866), effective June 9, 2025, with completion anticipated by August 31, 2028. This award funds the development and evaluation of neuroimaging biomarkers to characterize structural and functional network degeneration in Alzheimer's disease (AD). The research addresses a gap in the...
- Federal Grant Award Summary The University of Texas Southwestern Medical Center received a $3.18 million Project Grant from the National Institute on Aging (Aging Research program, CFDA 93.866) awarded August 13, 2025, with a completion date of July 31, 2029. This research initiative investigates the spatial organization and conformational ensembles of alpha-synuclein (α-syn) amyloids within cellular environments to advance understanding of neurodegenerative diseases including Lewy body...
- Federal Grant Award Summary The National Institute on Aging (NIA) awarded the University of Texas Medical Branch at Galveston a Project Grant totaling $548,723 under the Aging Research program (CFDA 93.866) for the period January 1, 2026 through December 31, 2030. This research award supports investigations into the interplay between microglia and tau oligomer polymorphs in cognitive resilience among Alzheimer's disease patients. The research will examine why certain individuals remain...
- Federal Grant Award Summary Oregon Health & Science University (OHSU) received a $471,885 Project Grant award from the National Institute on Aging under the Aging Research program (CFDA 93.866), effective June 1, 2025 through May 31, 2027. This award supports basic biomedical research directed at understanding the mechanisms of brain vascular endothelial cell (BVEC) disruption following vascular brain injury (VBI) and its contribution to vascular cognitive impairment and dementia (VCID). The...
The University of Texas Health Science Center at Houston received a $650,533 Project Grant from the National Institute on Aging (Aging Research program, CFDA 93.866) awarded February 1, 2026, with completion targeted for January 31, 2031. The grant supports biomedical research investigating the contribution of intramural von Willebrand factor (VWF) to cerebrovascular dysfunction in amyloidosis, particularly as it relates to cerebral amyloid angiopathy and Alzheimer's disease-related dementia. The funded research will advance understanding of how VWF accumulates within blood vessel walls and promotes vascular remodeling through smooth muscle cell proliferation, leveraging both clinical samples from patients with confirmed cerebral amyloid angiopathy and established mouse models of amyloidosis. The project delivers scientific investigation and experimental research services designed to elucidate the functional roles of perivascular VWF in vascular pathology and to identify potential therapeutic targets for reducing vascular remodeling through VWF depletion strategies. Research activities include controlled experiments manipulating perivascular VWF levels, morphological and cellular analyses of cerebral vasculature, and mechanistic studies examining smooth muscle cell behavior. Findings from this research will contribute to the National Institute on Aging's mission of supporting investigations into age-related neurodegeneration and dementia prevention and treatment approaches.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $650.5k | 1/22/26 |